Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine
Go back to Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine| (NASDAQ: LTRN) | Delayed: 1.55 -0.16 (9.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $ | |||
| Open | $1.75 | 52 Week Low | $ | |||
| Day High | $1.75 | P/E | N/A | |||
| Day Low | $1.55 | EPS | $ | |||
| Volume | 190,533 | |||||
